0378-2670Level 3
Phenytek (extended phenytoin sodium)
**Product type:** Human Prescription Drug
**Active ingredient:** PHENYTOIN SODIUM
**Strength:** 200 mg/1
**Dosage form:** Capsule, Extended Release
**Route:** Oral
**Labeler:** Mylan Pharmaceuticals Inc.
**Marketing category:** ANDA (ANDA040298)
**Pharmacologic class:** Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
GET
/api/v1/systems/ndc_fda/nodes/0378-2670Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.